The research at the CiiM aims to consequently promote personalisation of health care in infection medicine.
In individualised medicine specific requirements of patients or patient groups are taken into account for an optimal risk-benefit assessment and subsequently improved therapy outcome. Systematic diagnostics allow the stratification of patients and thereby targeted prevention and tailored therapies.
The potential of personalised approaches in infection medicine is currently being underutilised. But individual parameters as age, pre-existing conditions or genetic and physiological prerequisites have a substantial effect on the course of disease.
The existing translational expertise in the Hannover-Braunschweig region, modern technology platforms and infrastructures including relevant patient cohorts offer optimal conditions to establish the CiiM as an internationally leading centre for individualised infection medicine.
Being initially a virtual centre, the new CiiM groups will be housed at TWINCORE and will utilise infrastructures of the parental institutions to align, coordinate and further expand research activities in the field of personalised medicine. With the help of the established CiiM faculty team building among involved MHH, HZI and TWINCORE groups will be promoted as well as the coordinated expansion of infrastructure and target-aimed initial appointments for key disciplines will be made.